Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Sack

Showing results (41-50 of 277) with videos related to

Pageof 28
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2022
A polyvalent multiepitope protein cross-protects against <i>Vibrio cholerae</i> infection in rabbit colonization and passive protection modelsIpshita Upadhyay, Siqi Li, Galen Ptacek, et al.
International Journal of Epidemiology|October 30, 2016
Cholera cases cluster in time and space in Matlab, Bangladesh: implications for targeted preventive interventionsAmanda K Debes, Mohammad Ali, Andrew S Azman, et al.
Infection and Immunity|April 20, 2021
Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine CandidateHyesuk Seo, Carolina Garcia, Xiaosai Ruan, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IVXiaosai Ruan, David E Knudsen, Katie M Wollenberg, et al.
The American Journal of Tropical Medicine and Hygiene|December 9, 2016
Factors Associated with Fatal Outcomes Following Cholera-Like Syndrome in Far North Region of Cameroon: A Community-Based SurveyFabrice N Djouma, Jerome Ateudjieu, Malathi Ram, et al.
Journal of Clinical Microbiology|March 8, 2005
Genomic relatedness of the new Matlab variants of Vibrio cholerae O1 to the classical and El Tor biotypes as determined by pulsed-field gel electrophoresisAshrafus Safa, Nurul Amin Bhuiyan, Munirul Alam, et al.
Journal of Psychiatric Practice|September 27, 2005
A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate cravingJohn P Docherty, David A Sack, Mark Roffman, et al.
Health & Place|March 15, 2006
Efficacy calculation in randomized trials: global or local measures?Michael Emch, Mohammad Ali, Camilo Acosta, et al.
Microbiology Spectrum|February 16, 2024
MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic <i>Escherichia coli</i> (ETEC)Chongyang Zhang, Siqi Li, Ipshita Upadhyay, et al.
Gut Microbes|March 1, 2021
Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic <i>E. coli</i> infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge modelJessica Brubaker, Xueyan Zhang, A Louis Bourgeois, et al.
Pageof 28

Showing results (41-50 of 277) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2022
A polyvalent multiepitope protein cross-protects against <i>Vibrio cholerae</i> infection in rabbit colonization and passive protection modelsIpshita Upadhyay, Siqi Li, Galen Ptacek, et al.
International Journal of Epidemiology|October 30, 2016
Cholera cases cluster in time and space in Matlab, Bangladesh: implications for targeted preventive interventionsAmanda K Debes, Mohammad Ali, Andrew S Azman, et al.
Infection and Immunity|April 20, 2021
Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine CandidateHyesuk Seo, Carolina Garcia, Xiaosai Ruan, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IVXiaosai Ruan, David E Knudsen, Katie M Wollenberg, et al.
The American Journal of Tropical Medicine and Hygiene|December 9, 2016
Factors Associated with Fatal Outcomes Following Cholera-Like Syndrome in Far North Region of Cameroon: A Community-Based SurveyFabrice N Djouma, Jerome Ateudjieu, Malathi Ram, et al.
Journal of Clinical Microbiology|March 8, 2005
Genomic relatedness of the new Matlab variants of Vibrio cholerae O1 to the classical and El Tor biotypes as determined by pulsed-field gel electrophoresisAshrafus Safa, Nurul Amin Bhuiyan, Munirul Alam, et al.
Journal of Psychiatric Practice|September 27, 2005
A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate cravingJohn P Docherty, David A Sack, Mark Roffman, et al.
Health & Place|March 15, 2006
Efficacy calculation in randomized trials: global or local measures?Michael Emch, Mohammad Ali, Camilo Acosta, et al.
Microbiology Spectrum|February 16, 2024
MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic <i>Escherichia coli</i> (ETEC)Chongyang Zhang, Siqi Li, Ipshita Upadhyay, et al.
Gut Microbes|March 1, 2021
Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic <i>E. coli</i> infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge modelJessica Brubaker, Xueyan Zhang, A Louis Bourgeois, et al.
Pageof 28